Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Ductal, Breast

Explore clinical trials studying Carcinoma, Ductal, Breast. Study availability and eligibility vary by location and protocol.

60 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Ductal, Breast trial results

Completed

Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1

NCT02620280

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Brustgesundheitzentrum Tirol, Univ. Frauenklinik Innsbruck Innsbruck, Austria
  • Universitätsklinik für Innere Medizin III, mit Hämatologie, internistischer Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum Salzburg, Austria
  • Klinikum Augsburg International Patient Service Augsburg, Germany
  • Frauenarzt-Zentrum-Zehlendorf Berlin, Germany
View all 41 locations
View Trial Details
Completed

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

NCT00026286

Conditions
Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +17 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • Veterans Affairs Medical Center - Lakeside Chicago Chicago, Illinois, United States
  • CCOP - Central Illinois Decatur, Illinois, United States
View all 24 locations
View Trial Details
Completed

G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

NCT03455270

Conditions
Adenocarcinoma, Advanced Breast Cancer, Breast Cancer, +16 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Stanford Women Cancer Center Stanford, California, United States
  • Northwestern University - Feinberg School of Medicine Chicago, Illinois, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View all 15 locations
View Trial Details
Completed

Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer

NCT00694577

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions